Hart- en vaatziekten in Nederland 2010 - Nederlandse Hartstichting

91
13. MacGregor AJ, Canavan R, Knight C, Denton CP, Davar J, Coghlan J, et al. Pulmonary
hypertension in systemic sclerosis: risk factors for progression and consequences for survival.
Rheumatology (Oxford) 2001;40:453-9.
14. Morelli S, Barbieri C, Sgreccia A, Ferrante L, Pittoni V, Conti F, et al. Relationship between
cutaneous and pulmonary involvement in systemic sclerosis. J Rheumatol 1997;24:81-5.
15. Morgan C, Knight C, Lunt M, Black CM, Silman AJ. Predictors of end stage lung disease in a
cohort of patients with scleroderma. Ann Rheum Dis 2003;62:146-50.
16. Murata I, Takenaka K, Yoshinoya S, Kikuchi K, Kiuchi T, Tanigawa T, et al. Clinical evaluation
of pulmonary hypertension in systemic sclerosis and related disorders. A Doppler echo-
cardiographic study of 135 Japanese patients. Chest 1997;111:36-43.
17. Ungerer RG, Tashkin DP, Furst D, Clements PJ, Gong H, Jr., Bein M, et al. Prevalence and
clinical correlates of pulmonary arterial hypertension in progressive systemic sclerosis.
Am J Med 1983;75:65-74.
18. Yamane K, Ihn H, Asano Y, Yazawa N, Kubo M, Kikuchi K, et al. Clinical and laboratory
features of scleroderma patients with pulmonary hypertension. Rheumatology (Oxford)
2000;39:1269-71.
19. Asherson RA, Higenbottam TW, Dinh Xuan AT, Khamashta MA, Hughes GR. Pulmonary
hypertension in a lupus clinic: experience with twenty-four patients. J Rheumatol
1990;17:1292-8.
20. Pan TL, Thumboo J, Boey ML. Primary and secondary pulmonary hypertension in systemic
lupus erythematosus. Lupus 2000;9:338-42.
21. Thenappan T, Shah SJ, Rich S, Tian L, Archer SL, Gomberg-Maitland M. Survival in
pulmonary arterial hypertension: a reappraisal of the NIH risk stratification equation.
Eur Respir J 2010;35:1079-87.
Nederlandse Hartstichting / Pulmonale hypertensie bij volwassenen in Nederland